Down-regulation of EGFR protein either by siRNA or by a synthetic EGFR-down regulating peptide (Herdegradin) can kill prostate and ovarian cancer cells via selective mitophagy by activating the mTORC2/Akt axis (26). This evidence concerns the gene EGFR and ovarian cancer.